Apotea AB (publ)CHIX:APOTES 18 PB Ratio is 7.34 as of Jul. 11, 2026, which is 37% below its 10-year median of 11.64. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 608 Healthcare Providers & Services companies, Apotea AB (publ) ranks worse than 90.13% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Apotea AB (publ)'s share price is kr65.20. Apotea AB (publ)'s Book Value per Share for the quarter that ended in Mar. 2026 was kr8.88. Hence, Apotea AB (publ)'s PB Ratio of today is 7.34.
The historical rank and industry rank for Apotea AB (publ)'s PB Ratio or its related term are showing as below:
CHIX:APOTEs'
s PB Ratio Range Over the Past 10 Years
Min: 7 Med: 11.64 Max: 16.63
Current: 8.72
During the past 5 years, Apotea AB (publ)'s highest PB Ratio was 16.63. The lowest was 7.00. And the median was 11.64.
CHIX:APOTEs's PB Ratio is ranked worse than 90.13% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.99
vs CHIX:APOTEs: 8.72
During the past 12 months, Apotea AB (publ)'s average Book Value Per Share Growth Rate was 34.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 37.10% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Apotea AB (publ) was 37.10% per year. The lowest was 21.70% per year. And the median was 29.40% per year.
Back to Basics: PB Ratio
Apotea AB (publ) (CHIX:APOTEs) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Apotea AB (publ) PB Ratio Related Terms
Apotea AB (publ) PB Ratio Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s PB Ratio distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Apotea AB (publ) (CHIX:APOTES) has a PB Ratio of 7.34 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Apotea AB (publ) and its competitors. This is 37% below median its historical median of 11.64. Over the past decade, Apotea AB (publ)'s PB Ratio has ranged from 7.00 to 16.63. According to the industry distribution chart, Apotea AB (publ) ranks #548 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is Apotea AB (publ)'s PB Ratio too high?
Apotea AB (publ)'s current PB Ratio of 7.34 is 37% below median its 10-year median of 11.64. Over the past 10 years, this metric has ranged from a low of 7.00 to a high of 16.63. The Healthcare Providers & Services industry median PB Ratio is 1.99. Apotea AB (publ)'s value of 7.34 is 268.8% above this industry median. Based on the distribution chart, Apotea AB (publ) ranks #548 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #548 out of 608 companies for PB Ratio. This places Apotea AB (publ) in the lower half of its industry. The industry median PB Ratio is 1.99. Apotea AB (publ)'s value of 7.34 is 268.8% above this benchmark. Historically, Apotea AB (publ)'s own PB Ratio has ranged from 7.00 to 16.63 over the past decade. While the company's 10-year median is 11.64 vs. the industry median of 1.99, Apotea AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current PB Ratio of 7.34 is 268.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current PB Ratio is 7.34, which is 37% below median its own 10-year median of 11.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current PB Ratio of 7.34. The current PB Ratio is 7.34, which is 37% below median its 10-year median of 11.64 and 268.8% above the Healthcare Providers & Services industry median of 1.99. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current PB Ratio is 7.34 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for CHIX:APOTES
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:APOTES has been successfully added to your 
